Raymond James & Associates’s Gain Therapeutics GANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-260,019
| Closed | -$980K | – | 3959 |
|
|
2024
Q1 | $980K | Buy |
260,019
+236,231
| +993% | +$891K | ﹤0.01% | 2593 |
|
|
2023
Q4 | $77.7K | Sell |
23,788
-10,012
| -30% | -$32.7K | ﹤0.01% | 3631 |
|
|
2023
Q3 | $111K | Buy |
33,800
+400
| +1% | +$1.31K | ﹤0.01% | 3550 |
|
|
2023
Q2 | $150K | Buy |
33,400
+13,400
| +67% | +$60K | ﹤0.01% | 3508 |
|
|
2023
Q1 | $96.4K | Sell |
20,000
-4,000
| -17% | -$19.3K | ﹤0.01% | 3617 |
|
|
2022
Q4 | $75.1K | Hold |
24,000
| – | – | ﹤0.01% | 3629 |
|
|
2022
Q3 | $78K | Buy |
+24,000
| New | +$78K | ﹤0.01% | 3615 |
|